ANGO vs TROW · rev $292.5M vs P/E 12, rev $7.09B
AngioDynamics Inc (ANGO) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported TROW revenue for 2024-12-31 was $7.09B. Net income was $2.14B. Revenue was up 9.8% from 2023-12-31 to 2024-12-31. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
ANGO currently screens at market cap $378.5M. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the ANGO and TROW stock pages for the full models.
Not investment advice.